Royalty Pharma Plc (RPRX)

03:19 AM

Royalty Pharma stock hits 52-week high at $41.26 By Investing.com - Investing.com Australia

03:19 AM

10:55 AM

Royalty Pharma (NASDAQ:RPRX) Sets New 1-Year HighHere's Why - MarketBeat

10:55 AM

03:35 AM

United StatesGoodwin Guides Royalty Pharma On Acquisition Of Remaining Royalty Interest In Roche’s Evrysdi For $240 Million And Potential Milestones - Mondaq

03:35 AM

03:00 AM

Royalty Pharma plc (NASDAQ:RPRX) Nasdaq Index Life Sciences Partner - Kalkine Media

03:00 AM

Jan 04, 2026

Financiere des Professionnels Fonds d investissement inc. Invests $933,000 in Royalty Pharma PLC $RPRX - MarketBeat

Jan 04, 2026

Jan 04, 2026

Royalty Pharma Acquires Remaining Royalty Interest in Roche’s Evrysdi for $240 Million and Potential Milestones - citybiz

Jan 04, 2026

Jan 02, 2026

Why (RPRX) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Jan 02, 2026

Dec 31, 2025

What's Going On With Royalty Pharma Stock Wednesday?Royalty Pharma (NASDAQ:RPRX) - Benzinga

Dec 31, 2025

Dec 30, 2025

Royalty Pharma buys remaining royalty interest in Roche drug Evrysdi - MSN

Dec 30, 2025

Dec 29, 2025

Royalty Pharma Acquires Remaining Evrysdi Royalties From PTC Therapeutics - Nasdaq

Dec 29, 2025

Dec 29, 2025

Royalty Pharma acquires final portion of Evrysdi royalty for $240 million By Investing.com - Investing.com Nigeria

Dec 29, 2025

Dec 29, 2025

PTC Therapeutics IncCo, Royalty Pharma Inv - 富途牛牛

Dec 29, 2025

Dec 29, 2025

Royalty Pharma acquires remaining royalty interest in Roche's Evrysdi for $240 million - MarketScreener

Dec 29, 2025

Dec 29, 2025

Royalty Pharma Buys Remaining Royalty Interest in Roche's Evrysdi - MarketScreener

Dec 29, 2025

Dec 29, 2025

Royalty Pharma acquires final portion of Evrysdi royalty for $240 million - Investing.com

Dec 29, 2025

Dec 29, 2025

Royalty Pharma (NASDAQ:RPRX) EVP Sells $786,400.00 in Stock - MarketBeat

Dec 29, 2025

Dec 29, 2025

Royalty Pharma stock rises after acquiring full Evrysdi royalty By Investing.com - Investing.com Canada

Dec 29, 2025

Dec 29, 2025

Royalty Pharma stock rises after acquiring full Evrysdi royalty - Investing.com

Dec 29, 2025

Dec 29, 2025

Royalty Pharma Acquires Final Portion of Evrysdi Royalty from PTC Therapeutics for $240 Million - Quiver Quantitative

Dec 29, 2025

Dec 29, 2025

Royalty Pharma acquires remaining Evrysdi royalty for $240 million - StreetInsider

Dec 29, 2025

Dec 29, 2025

Nuvalent’s royalty interest acquired by Royalty Pharma - MSN

Dec 29, 2025

Dec 29, 2025

Royalty Pharma PLC $RPRX Shares Sold by Marathon Asset Management Ltd - MarketBeat

Dec 29, 2025

Dec 29, 2025

Royalty Pharma announces planned legal leadership transition - MSN

Dec 29, 2025

Dec 28, 2025

Royalty Pharma Plc's (NASDAQ:RPRX) Earnings Haven't Escaped The Attention Of Investors - 富途牛牛

Dec 28, 2025

Dec 28, 2025

World Investment Advisors Takes $1.70 Million Position in Royalty Pharma PLC $RPRX - MarketBeat

Dec 28, 2025

Dec 27, 2025

Can Royalty Pharma plc (RPD) stock ride next bull market cycleReal Estate Investment Trusts & Capitalize On Fast Trends - bollywoodhelpline.com

Dec 27, 2025

Dec 25, 2025

Royalty Pharma PLC $RPRX Stock Holdings Lifted by Voya Investment Management LLC - MarketBeat

Dec 25, 2025

Dec 24, 2025

Swedbank AB Acquires 42,800 Shares of Royalty Pharma PLC $RPRX - MarketBeat

Dec 24, 2025

Dec 24, 2025

Friedenthal Financial Acquires Shares of 29,322 Royalty Pharma PLC $RPRX - MarketBeat

Dec 24, 2025

Dec 23, 2025

Royalty Pharma (RPRX): Reassessing Valuation After MYQORZO’s FDA Approval Unlocks New Royalty Cash Flows - Sahm

Dec 23, 2025

Dec 22, 2025

Royalty Pharma (NASDAQ:RPRX) EVP Sells $767,600.00 in Stock - MarketBeat

Dec 22, 2025

Dec 22, 2025

Royalty Pharma Announces Planned Legal Leadership Transition - TipRanks

Dec 22, 2025

Dec 22, 2025

Royalty Pharma names McGivern as chief legal officer - StreetInsider

Dec 22, 2025

Dec 22, 2025

Royalty Pharma plc Announces Executive Changes - marketscreener.com

Dec 22, 2025

Dec 22, 2025

The Technical Signals Behind (RPRX) That Institutions Follow - Stock Traders Daily

Dec 22, 2025

Dec 22, 2025

Royalty Pharma Gains from MYQORZO FDA Approval - TradingView — Track All Markets

Dec 22, 2025

Dec 19, 2025

Royalty Pharma (NASDAQ:RPRX) EVP Sells $3,060,375.22 in Stock - MarketBeat

Dec 19, 2025

Dec 19, 2025

Insider Selling: Royalty Pharma (NASDAQ:RPRX) EVP Sells 30,654 Shares of Stock - MarketBeat

Dec 19, 2025

Dec 19, 2025

Royalty Pharma : Q4 2025 Pre-Quarterly Results Communication - marketscreener.com

Dec 19, 2025

Dec 18, 2025

How risky is Royalty Pharma plc (RPD) stock compared to peersPortfolio Update Summary & AI Powered Buy and Sell Recommendations - ulpravda.ru

Dec 18, 2025

Dec 18, 2025

Royalty Pharma PLC $RPRX Shares Sold by Thrivent Financial for Lutherans - MarketBeat

Dec 18, 2025

Dec 18, 2025

Dividend Watch: How Royalty Pharma plc stock compares to growth peers - Улправда

Dec 18, 2025

Dec 17, 2025

Insider Selling: Royalty Pharma (NASDAQ:RPRX) CFO Sells 69,582 Shares of Stock - MarketBeat

Dec 17, 2025

Dec 17, 2025

Royalty Pharma (NASDAQ:RPRX) EVP Marshall Urist Sells 20,000 Shares - MarketBeat

Dec 17, 2025

Dec 17, 2025

Royalty Pharma Insider Sold Shares Worth $766,420, According to a Recent SEC Filing - marketscreener.com

Dec 17, 2025

Dec 17, 2025

VP Urist Sells 20,000 ($766.4K) Of Royalty Pharma PLC [RPRX] - TradingView — Track All Markets

Dec 17, 2025

Dec 17, 2025

[Form 4] Royalty Pharma plc Insider Trading Activity - Stock Titan

Dec 17, 2025

Dec 17, 2025

UBS reiterates Buy rating on Nuvalent stock, citing Royalty Pharma deal - Investing.com Nigeria

Dec 17, 2025

Dec 17, 2025

Royalty Pharma buys royalty interest in Nuvalent cancer drugs for up to $315 mln - MSN

Dec 17, 2025